The Impact of Innovation on the Profitability of Slovak Pharmaceutical Companies

IF 1.2 Q4 MANAGEMENT
S. Lehenchuk, M. Tumpach, I. Vyhivska, V. Makarovych, S. Laichuk
{"title":"The Impact of Innovation on the Profitability of Slovak Pharmaceutical Companies","authors":"S. Lehenchuk, M. Tumpach, I. Vyhivska, V. Makarovych, S. Laichuk","doi":"10.21272/mmi.2022.2-25","DOIUrl":null,"url":null,"abstract":"In conditions of the knowledge economy and innovations, research and development activities are among the most important factors affecting companies' financial performance. This study aims to investigate the impact of research and development activities on the profitability of Slovak pharmaceutical companies. The panel dataset consists of 37 sample pharmaceutical companies for 2015-2019. Panel data regression analysis was used as the main research method of the study. Profitability was measured with the return on assets indicator, chosen as the dependent variable. The independent variables are leverage, research and development intensity, research and development intensity squared, size, and high-tech dummy. The empirical analysis includes descriptive statistics, normality test, autocorrelation test, and panel regression models (random effect model) followed by F-statistics test, Hausman test, and Breusch-Pagan test. The hypothesis that there is a significant positive impact of research and development activities on the profitability of knowledge-intensive enterprises has been partly confirmed. Only the research and development intensity squared has a significant positive impact on the profitability of Slovak pharmaceutical companies at a 1% level. On the contrary, the research and development intensity has a significant negative relation. According to the analysis results, control variables (leverage, size, and high-tech dummy) have no significant influence on profitability. The existence of an inverted-U relationship between research and development activities and the profitability of Slovak pharmaceutical companies has been established. Investing in innovations of Slovak pharmaceutical companies has a positive effect on profitability only from a certain amount and has an upper limit on the amount of profitable investment. Thus, to formulate recommendations on the adjustment of investment policy in research and development activities, it is necessary to conduct future research to determine the entry points and exit points from the area of best profitability on inverted-U function.","PeriodicalId":45989,"journal":{"name":"Marketing and Management of Innovations","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Marketing and Management of Innovations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21272/mmi.2022.2-25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MANAGEMENT","Score":null,"Total":0}
引用次数: 5

Abstract

In conditions of the knowledge economy and innovations, research and development activities are among the most important factors affecting companies' financial performance. This study aims to investigate the impact of research and development activities on the profitability of Slovak pharmaceutical companies. The panel dataset consists of 37 sample pharmaceutical companies for 2015-2019. Panel data regression analysis was used as the main research method of the study. Profitability was measured with the return on assets indicator, chosen as the dependent variable. The independent variables are leverage, research and development intensity, research and development intensity squared, size, and high-tech dummy. The empirical analysis includes descriptive statistics, normality test, autocorrelation test, and panel regression models (random effect model) followed by F-statistics test, Hausman test, and Breusch-Pagan test. The hypothesis that there is a significant positive impact of research and development activities on the profitability of knowledge-intensive enterprises has been partly confirmed. Only the research and development intensity squared has a significant positive impact on the profitability of Slovak pharmaceutical companies at a 1% level. On the contrary, the research and development intensity has a significant negative relation. According to the analysis results, control variables (leverage, size, and high-tech dummy) have no significant influence on profitability. The existence of an inverted-U relationship between research and development activities and the profitability of Slovak pharmaceutical companies has been established. Investing in innovations of Slovak pharmaceutical companies has a positive effect on profitability only from a certain amount and has an upper limit on the amount of profitable investment. Thus, to formulate recommendations on the adjustment of investment policy in research and development activities, it is necessary to conduct future research to determine the entry points and exit points from the area of best profitability on inverted-U function.
创新对斯洛伐克制药公司盈利能力的影响
在知识经济和创新的条件下,研究和开发活动是影响公司财务绩效的最重要因素之一。本研究旨在调查研究和开发活动对斯洛伐克制药公司盈利能力的影响。面板数据集由2015-2019年的37家样本制药公司组成。本研究采用面板数据回归分析作为主要研究方法。以资产收益率指标作为因变量来衡量盈利能力。自变量为杠杆、研发强度、研发强度平方、规模、高科技假人。实证分析包括描述性统计、正态性检验、自相关检验和面板回归模型(随机效应模型),然后进行f统计检验、Hausman检验和Breusch-Pagan检验。研究与开发活动对知识密集型企业盈利能力有显著正向影响的假设部分得到了证实。只有研发强度的平方在1%的水平上对斯洛伐克制药公司的盈利能力有显著的正影响。相反,研发强度呈显著负相关。从分析结果来看,控制变量(杠杆、规模、高科技假人)对盈利能力的影响不显著。研究和开发活动与斯洛伐克制药公司的盈利能力之间存在倒u型关系。斯洛伐克制药公司的创新投资仅在一定数量上对盈利能力产生积极影响,并且对盈利投资的数量有上限。因此,为了制定调整研发活动投资政策的建议,有必要进行未来的研究,以确定从倒u函数的最佳盈利区域的切入点和退出点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
7.70%
发文量
9
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信